Evidence map›Paper›PMID 37639324›Full record

ArticleBlood advances2023

Inflammatory reactions mimic residual or recurrent lymphoma on [18F]FDG-PET/CT after CD19-directed CAR T-cell therapy.

Janneke W de Boer, Elise R A Pennings, Ankie Kleinjan, Jaap A van Doesum, Anne M Spanjaart, Pim G N J Mutsaers, Margot Jak, Marjolein W M van der Poel, Maria T Kuipers, Judit A Adam and 7 more

Open access · goldAbstract read
In one paragraph

Article in Blood advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. The Role of [Tomography (Ann Arbor, Mich.) · 2024
    Pooled it
  2. Nature communications · 2024
    Trial
  3. Standardized FDG-PET interpretation during CAR T-cell therapy in R/R DLBCL: a DESCAR-T study.European journal of nuclear medicine and molecular imaging · 2026
    Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 1 country.

Janneke W de BoerDepartment of Hematology, University Medical Center Groningen, Groningen, The Netherlands.ORCID 0000-0002-0221-1835
Elise R A PenningsDepartment of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0001-7674-2148
Ankie KleinjanDepartment of Internal Medicine, Rivierenland Hospital, Tiel, The Netherlands.
Jaap A van DoesumDepartment of Hematology, University Medical Center Groningen, Groningen, The Netherlands.ORCID 0000-0003-0214-3219
Anne M SpanjaartDepartment of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.
Pim G N J MutsaersDepartment of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.ORCID 0000-0002-3924-8578
Margot JakDepartment of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID 0000-0001-8092-3566
Marjolein W M van der PoelDepartment of Internal Medicine, Division of Hematology, GROW school for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.
Maria T KuipersCancer Center Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0003-4327-2316
Judit A AdamCancer Center Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0001-8899-8087
Arjan DiepstraDepartment of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.ORCID 0000-0001-9239-1050
Lianne KoensDepartment of Pathology, Cancer Center Amsterdam, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.
Suzanne van DorpDepartment of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
Joost S P VermaatDepartment of Hematology, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0002-1628-6256
Anne G H NiezinkDepartment of Radiation Oncology, University Medical Center Groningen, Groningen, The Netherlands.
Marie José KerstenDepartment of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0002-8904-3802
Tom van MeertenDepartment of Hematology, University Medical Center Groningen, Groningen, The Netherlands.ORCID 0000-0002-5581-6950
Amsterdam University Medical Centers · NLUniversity Medical Center Groningen · NLErasmus MC Cancer Institute · NLLeiden University Medical Center · NLMaastricht University · NLRadboud University Nijmegen · NLUniversity Medical Center Utrecht · NLZiekenhuis Rivierenland · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Fluorodeoxyglucose F18LymphomaAntigens, CD19HumansImmunotherapy, AdoptiveNeoplasm Recurrence, LocalPositron Emission Tomography Computed TomographyAntigens, CD19Fluorodeoxyglucose F18

Identifiers

PMID37639324
PMCPMC10641469
OpenAlexW4386225316

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.